EASiVENT Study Comparing INTELLiVENT-ASV vs Non Automated Ventilation in Adult ICU Patients

NCT ID: NCT04400643

Last Updated: 2024-10-23

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-20

Study Completion Date

2022-07-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to assess the safety and efficacy of INTELLiVENT-ASV (Adaptive Support Ventilation) in adult ICU patients comparing to non automated ventilation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

EASiVENT is a prospective, multicenter, randomized (1:1), Controlled Study. This study is single-blind because only the subject will be unaware of the ventilation modality administered. The reference treatment used for comparison is a combination of controlled modes for passive subjects (volume control or pressure control) and assisted/spontaneous modes for active subjects (synchronized intermittent mechanical ventilation or pressure support)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Failure Coma Acute Respiratory Distress Syndrome (ARDS) Chronic Obstructive Pulmonary Disease (COPD) Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

INTELLiVENT-ASV

INTELLiVENT-ASV is a software accessory that automatically adjusts ventilation and oxygenation variables to keep the patient within clinician-set target ranges, from intubation until extubation.

Group Type EXPERIMENTAL

INTELLiVENT-ASV

Intervention Type DEVICE

INTELLiVENT-ASV is software accessory that automatically adjust ventilation and oxygenation variables to keep the patient within clinician-set target ranges.

Non-Automated ventilation

In conventional ventilation modes, clinicians adjust and modify the oxygenation and ventilation parameters manually.

Group Type ACTIVE_COMPARATOR

Non-automated ventilation

Intervention Type DEVICE

In conventional ventilation modes, clinicians adjust and modify the oxygenation and ventilation parameters manually.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

INTELLiVENT-ASV

INTELLiVENT-ASV is software accessory that automatically adjust ventilation and oxygenation variables to keep the patient within clinician-set target ranges.

Intervention Type DEVICE

Non-automated ventilation

In conventional ventilation modes, clinicians adjust and modify the oxygenation and ventilation parameters manually.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Weight greater than 40 kg
* Under invasive ventilation
* Expected to be mechanically ventilated after enrollment for at least 24 hours
* Agrees to not participate in other interventional research studies involving mechanical ventilation for the duration of study
* Signature of the informed consent by the patient or his/her next-of-kin according to country or state regulation.

Exclusion Criteria

* Fulfilling weaning criteria according to the weaning procedure of the ICU
* Need for "rescue therapy" (e.g: ECMO)
* Brain death status
* Respiratory drive disorder (Cheyne-Stokes breathing)
* Arterial hypoxia due to a non-pulmonary condition (right-to-left shunting due to congenital disease, hepato-pulmonary syndrome, )
* Broncho-pleural fistula
* Chronic or acute dyshemoglobinemia: eg.: acute CO poisoning
* Chronic respiratory failure requiring long term invasive ventilation;
* Moribund patient
* Patient under guardianship, deprived of liberties
* Any other condition, that in the opinion of the IoR/designee, would preclude informed consent (by the spouse/next of kin), make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
* Low quality index on the SpO2 (Oxygen Saturation Measured by Pulse Oximetry) measurement
* Patients already enrolled in the present study in a previous episode of acute respiratory failure
* High PaCO2 - ETCO2 gap (\> 2.6 kPa or 19.5 mmHg) for \> 3 hours
* Patient tracheostomized at the time of inclusion
* Patient ventilated with helium
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hamilton Medical AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centro Hospitalar Universitário de Lisboa Central

Lisbon, , Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EASiVENT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NIV for COPD: Hospital to Home
NCT04413643 TERMINATED NA